Related Experiment Video
Updated: Dec 29, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
A standardised method for use of the Leksell GammaPlan Inverse Planning module for metastases
Peter Fallows1, Gavin Wright1, Peter Bownes1
1Leeds Cancer Centre, Leeds Teaching Hospitals, Leeds, United Kingdom.
Aim:
The aim of this investigation was to develop a standardised method for using the inverse planning module in Leksell GammaPlan.
Methods:
Leksell GammaPlan version 10 and higher contains an inverse planning module, consisting of functions to automatically fill a target volume with shots and subsequently optimise their resulting dosimetry. A standardised method for using the inverse planning module was developed for metastases, using the following optimisation parameter weightings: {coverage 0.9, selectivity 0.1, gradient index (GI) 0.2, }. 25 plans produced using these parameters were compared to manually produced clinical plans. Additionally, the 25 plans were manually adjusted to match the coverage of the clinical plans, and comparison of the PCI, GI and BOT was made.
Results:
The average parameters for plans produced using the optimisation module were; coverage 98.7%; Paddick conformity index (PCI) 0.85; GI 2.75, compared to coverage 99.5%; PCI 0.83; GI 2.70 for manual clinical plans with BOT 21% shorter than clinical plans on average. The average parameters for the plans produced by the optimisation module after manual adjustment to match the coverage of the clinical plans were: coverage 99.5, PCI 0.83, GI 2.73 with BOT 16% shorter than clinical plans on average.
Conclusions:
The standardised method for using the optimisation module has potential for shortening treatment times and planning times.
More Related Videos
08:25Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022